| Balance Sheet of Zydus Lifesciences (in Rs. Cr.) |
Mar 15 |
Mar 14 |
Mar 13 |
Mar 12 |
Mar 11 |
|
| |
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| EQUITIES AND LIABILITIES |
|
|
|
|
|
|
| SHAREHOLDER'S FUNDS |
|
|
|
|
|
|
| Equity Share Capital |
102.40 |
102.40 |
102.40 |
102.40 |
102.40 |
|
| Total Share Capital |
102.40 |
102.40 |
102.40 |
102.40 |
102.40 |
|
| Reserves and Surplus |
4,149.20 |
3,336.60 |
2,842.10 |
2,471.20 |
2,069.10 |
|
| Total Reserves and Surplus |
4,149.20 |
3,336.60 |
2,842.10 |
2,471.20 |
2,069.10 |
|
| Total Shareholders Funds |
4,251.60 |
3,439.00 |
2,944.50 |
2,573.60 |
2,171.50 |
|
| Minority Interest |
168.90 |
144.30 |
119.30 |
90.40 |
66.90 |
|
| NON-CURRENT LIABILITIES |
|
|
|
|
|
|
| Long Term Borrowings |
1,150.40 |
1,362.20 |
1,426.00 |
1,322.30 |
762.90 |
|
| Deferred Tax Liabilities [Net] |
58.60 |
96.10 |
100.50 |
118.50 |
112.70 |
|
| Other Long Term Liabilities |
42.10 |
54.80 |
47.00 |
42.60 |
18.80 |
|
| Long Term Provisions |
110.60 |
76.10 |
64.50 |
75.60 |
61.90 |
|
| Total Non-Current Liabilities |
1,361.70 |
1,589.20 |
1,638.00 |
1,559.00 |
956.30 |
|
| CURRENT LIABILITIES |
|
|
|
|
|
|
| Short Term Borrowings |
1,183.50 |
902.40 |
1,257.10 |
687.10 |
259.80 |
|
| Trade Payables |
1,090.90 |
910.80 |
656.80 |
545.50 |
570.60 |
|
| Other Current Liabilities |
628.20 |
708.10 |
509.20 |
692.40 |
367.30 |
|
| Short Term Provisions |
362.30 |
292.70 |
247.30 |
228.10 |
218.20 |
|
| Total Current Liabilities |
3,264.90 |
2,814.00 |
2,670.40 |
2,153.10 |
1,415.90 |
|
| Total Capital And Liabilities |
9,047.10 |
7,986.50 |
7,372.20 |
6,379.20 |
4,610.60 |
|
| ASSETS |
|
|
|
|
|
|
| NON-CURRENT ASSETS |
|
|
|
|
|
|
| Tangible Assets |
2,417.50 |
2,157.60 |
2,020.20 |
1,752.60 |
1,257.20 |
|
| Intangible Assets |
934.70 |
966.20 |
1,005.40 |
1,095.30 |
575.40 |
|
| Capital Work-In-Progress |
797.90 |
891.50 |
735.60 |
449.20 |
396.30 |
|
| Fixed Assets |
4,150.10 |
4,015.30 |
3,761.20 |
3,331.80 |
2,263.60 |
|
| Non-Current Investments |
33.20 |
22.20 |
21.20 |
21.20 |
20.70 |
|
| Deferred Tax Assets [Net] |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Long Term Loans And Advances |
637.10 |
495.30 |
398.10 |
263.10 |
201.00 |
|
| Other Non-Current Assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Total Non-Current Assets |
4,820.40 |
4,532.80 |
4,180.50 |
3,616.10 |
2,485.30 |
|
| CURRENT ASSETS |
|
|
|
|
|
|
| Current Investments |
121.20 |
64.40 |
93.30 |
3.00 |
0.00 |
|
| Inventories |
1,535.70 |
1,367.50 |
1,213.60 |
1,090.50 |
811.90 |
|
| Trade Receivables |
1,588.40 |
1,133.70 |
955.10 |
886.30 |
765.20 |
|
| Cash And Cash Equivalents |
669.90 |
548.80 |
583.80 |
466.60 |
295.20 |
|
| Short Term Loans And Advances |
240.80 |
270.70 |
279.00 |
274.60 |
206.20 |
|
| OtherCurrentAssets |
70.70 |
68.60 |
66.90 |
42.10 |
46.80 |
|
| Total Current Assets |
4,226.70 |
3,453.70 |
3,191.70 |
2,763.10 |
2,125.30 |
|
| Total Assets |
9,047.10 |
7,986.50 |
7,372.20 |
6,379.20 |
4,610.60 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
|
|
| CONTINGENT LIABILITIES, COMMITMENTS |
|
|
|
|
|
|
| Contingent Liabilities |
513.60 |
311.50 |
406.80 |
598.00 |
288.90 |
|
| BONUS DETAILS |
|
|
|
|
|
|
| Bonus Equity Share Capital |
72.97 |
72.97 |
72.97 |
72.97 |
72.97 |
|
| NON-CURRENT INVESTMENTS |
|
|
|
|
|
|
| Non-Current Investments Quoted Market Value |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Non-Current Investments Unquoted Book Value |
1.70 |
2.30 |
20.00 |
20.00 |
19.50 |
|
| CURRENT INVESTMENTS |
|
|
|
|
|
|
| Current Investments Quoted Market Value |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Current Investments Unquoted Book Value |
0.70 |
0.60 |
80.40 |
3.00 |
0.00 |
|
Source : Dion Global Solutions Limited
